ADC Therapeutics Raises $76m To Keep ADC Development Momentum Going

 
• By Mandy Jackson

The company extended its series E financing to $276m to keep its two lead ADC candidates moving toward pivotal data and BLA filings, including a planned filing for ADCT-402 late next year. The funding news comes as the ADC field moves into the spotlight.

Stack-100 bills
ADC Therapeutics has raised $531m since 2011 • Source: Shutterstock

More from Financing

More from Business